×
About 39,618 results

ALLMedicine™ Migraine Center

Research & Reviews  11,043 results

The role of cytokines in migraine: A systematic review.
https://doi.org/10.1177/03331024221118924
Cephalalgia : an International Journal of Headache; Thuraiaiyah J, Erritzøe-Jervild M et. al.

Aug 14th, 2022 - Cytokines are important endogenous substances that are involved in immune and inflammatory responses. Neurogenic inflammation has been proposed to play a role in migraine involving altered cytokine levels. Therefore, we aimed to provide a systemat...

Behavioral Patterns of Depression Patients and Control Population.
https://doi.org/10.3390/ijerph19159506
International Journal of Environmental Research and Publi... Carreira-Míguez M, Navarro-Jiménez E et. al.

Aug 13th, 2022 - Behavioral and multifactorial factors, such as psychological, nutritional, dental pathology, and physical activity habits, are factors that control depression. The objective of the present study was to analyze the differences in the behavioral, ps...

Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from m...
https://doi.org/10.1186/s10194-022-01468-y
The Journal of Headache and Pain; Magdy R, Elmazny A et. al.

Aug 13th, 2022 - The burden of post-coronavirus disease (COVID)-19 symptoms has been increasing and is of great concern in patients with pre-existing chronic medical conditions.This study aimed to delineate the post-COVID-19 neuropsychiatric symptoms among migrain...

Association Between Computer Vision Syndrome, Insomnia, and Migraine Among Lebanese Adu...
https://doi.org/10.4088/PCC.21m03083
The Primary Care Companion for CNS Disorders; Akiki M, Obeid S et. al.

Aug 13th, 2022 - Objective: Computer vision syndrome (CVS) refers to a group of ocular and extraocular symptoms due to prolonged digital device screen use. The objective of this study was to assess the correlation between CVS, insomnia, and migraine, taking into c...

OTC Analgesics vs Opioids for Pain Management.
https://doi.org/10.12788/jfp.0418
The Journal of Family Practice; Ruoff GM

Aug 13th, 2022 - The use of opioids in acute pain may be appropriate in some situations, but there are opportunities to reduce exposure to opioids with equally effective monotherapy and combination therapy over-thecounter (OTC) medications. There are a number of O...

see more →

Guidelines  16 results

Guidelines of the International Headache Society for controlled trials of preventive tr...
https://doi.org/10.1177/0333102420941839
Cephalalgia : an International Journal of Headache; Diener HC, Tassorelli C et. al.

Jul 30th, 2020 - Clinical trials are a key component of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Contro...

ACR Appropriateness Criteria® Cerebrovascular Disease-Child.
https://doi.org/10.1016/j.jacr.2020.01.036
Journal of the American College of Radiology : JACR; , Robertson RL et. al.

May 7th, 2020 - Stroke is an uncommon but an important and under-recognized cause of morbidity and mortality in children. Strokes may be due to either brain ischemia or intracranial hemorrhage. Common symptoms of pediatric acute stroke include headache, vomiting,...

Transcranial Magnetic Stimulation for Pain, Headache, and Comorbid Depression: INS-NANS...
https://doi.org/10.1111/ner.13094
Neuromodulation : Journal of the International Neuromodul... Leung A, Shirvalkar P et. al.

Mar 27th, 2020 - While transcranial magnetic stimulation (TMS) has been studied for the treatment of psychiatric disorders, emerging evidence supports its use for pain and headache by stimulating either motor cortex (M1) or dorsolateral prefrontal cortex (DLPFC). ...

Pharmacologic Acute and Preventive Treatment for Migraine in Children and Adolescents.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074018
JAMA Neurology; Szperka CL, VanderPluym JH et. al.

Dec 10th, 2019 - Pharmacologic Acute and Preventive Treatment for Migraine in Children and Adolescents.|2019|Szperka CL,VanderPluym JH,Oakley CB,|prevention & control,

Aids to management of headache disorders in primary care (2nd edition) : on behalf of t...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734476
The Journal of Headache and Pain; Steiner TJ, Jensen R et. al.

May 23rd, 2019 - The Aids to Management are a product of the Global Campaign against Headache, a worldwide programme of action conducted in official relations with the World Health Organization. Developed in partnership with the European Headache Federation, they ...

see more →

Drugs  830 results see all →

Clinicaltrials.gov  1,332 results

Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine
https://clinicaltrials.gov/ct2/show/NCT05028569

Aug 12th, 2022 - Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound (ICHD 2018). Migraine can be further categorized according to the frequency of attacks as epis...

Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine
https://clinicaltrials.gov/ct2/show/NCT04252742

Aug 12th, 2022 - The primary objective of this study is to evaluate the treatment benefit of erenumab on headache duration of at least moderate pain intensity.

Study Evaluated the Effectiveness of Milnacipran to Reduce Pain Levels in Individuals With Chronic Migraine
https://clinicaltrials.gov/ct2/show/NCT01393522

Aug 12th, 2022 - Milnacipran is a serotonin norepinephrine reubtake inhibitor (SNRI) approved for the management of fibromyalgia in the United States. Migraine and fibromyalgia have significant co-morbidity. Of 100 patients with fibromyalgia, 76% had chronic heada...

Effectiveness of a Dialogue-based Online Intervention Against Migraine
https://clinicaltrials.gov/ct2/show/NCT04276142

Aug 12th, 2022 - Migraine is common in the German population and leads to a decreased quality of life as well as high economic consequences. Cognitive behavioural therapy has shown to be effective in the treatment of migraine. Web-based psychological interventions...

Transcutaneous Pulsed Radiofrequency in Migraine
https://clinicaltrials.gov/ct2/show/NCT05499689

Aug 12th, 2022 - Migraine is the second most common primary headache. Greater occipital nerve (GON) block is an effective method in the treatment of migraine. Transcutaneous pulsed radiofrequency (RF) therapy is used in the treatment of pain. However, its use in h...

see more →

News  2,593 results

Commentary: Comparing Migraine Treatments, August 2022
https://www.mdedge.com/migraine-icymi/article/256990/headache-migraine/commentary-comparing-migraine-treatments-august-2022
Thomas Berk, MD

Aug 11th, 2022 - Migraine is a unique neurologic condition, in that a person can't prove they have it and there are few objective tools neurologists have to guide their diagnostic process. The recognition of the role of the vasoactive peptide calcitonin gene-relat.

Large Study Confirms COVID Vaccines Safe for Pregnant Women
https://www.medscape.com/viewarticle/979114

Aug 11th, 2022 - Pregnant women should feel confident that Pfizer's and Moderna's vaccines against COVID-19 are safe, according to a large new study published today. In fact, pregnant vaccinated women had lower odds of a significant health event, compared with non...

Episodes of visual disturbance
https://www.mdedge.com/migraine-challenge-center/article/256718/migraine/episodes-visual-disturbance

Aug 1st, 2022 - On the basis of the history, examination, and investigations, retinal migraine was diagnosed according to the International Classification of Headache Disorders, third edition (1. 2 migraine with aura; 1.

Efficacy and safety of external concurrent occipital and trigeminal neurostimulation in migraine treatment
https://www.mdedge.com/migraine-icymi/article/256671/headache-migraine/efficacy-and-safety-external-concurrent-occipital

Jul 31st, 2022 - Key clinical point: External concurrent occipital and trigeminal neurostimulation (eCOT-NS) was well tolerated, safe, and an effective treatment that provided fast and durable relief and freedom from pain in patients with migraine with or without.

Vitamin D3 supplementation to topiramate therapy shows promise for pediatric migraine
https://www.mdedge.com/migraine-icymi/article/256670/headache-migraine/vitamin-d3-supplementation-topiramate-therapy-shows

Jul 31st, 2022 - Key clinical point: Vitamin D3 (5000 IU daily) supplementation as an adjuvant therapy to topiramate was well tolerated and safe, and an effective strategy for pediatric migraine prophylaxis. Major finding: After 16 weeks of treatment, the monthly.

see more →

Patient Education  33 results see all →